Detalhe da pesquisa
1.
Site-Selective Polyfluoroaryl Modification and Unsymmetric Stapling of Unprotected Peptides.
J Am Chem Soc
; 146(10): 6675-6685, 2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38427024
2.
The Peptide DHα-(4-pentenyl)-ANPQIR-NH2 Exhibits Antifibrotic Activity in Multiple Pulmonary Fibrosis Models Induced by Particulate and Soluble Chemical Fibrogenic Agents.
J Pharmacol Exp Ther
; 388(2): 701-714, 2024 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38129127
3.
The novel peptide DR4penA attenuates the bleomycin- and paraquat-induced pulmonary fibrosis by suppressing the TGF-ß/Smad signaling pathway.
FASEB J
; 37(11): e23225, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37855708
4.
ß-Arrestin 1 has an essential role in neurokinin-1 receptor-mediated glioblastoma cell proliferation and G2/M phase transition.
J Biol Chem
; 292(21): 8933-8947, 2017 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-28341744
5.
Novel antimicrobial peptides modified with fluorinated sulfono-γ-AA having high stability and targeting multidrug-resistant bacteria infections.
Eur J Med Chem
; 264: 116001, 2024 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38056301
6.
Novel Peptide DR3penA as a Low-Toxicity Antirenal Fibrosis Agent by Suppressing the TGF-ß1/miR-212-5p/Low-Density Lipoprotein Receptor Class a Domain Containing 4/Smad Axis.
ACS Pharmacol Transl Sci
; 7(4): 1126-1141, 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38633584
7.
Novel Feleucin-K3-Derived Peptides Modified with Sulfono-γ-AA Building Blocks Targeting Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus Infections.
J Med Chem
; 66(2): 1254-1272, 2023 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36350686
8.
Neurokinin-1 receptor drives PKCÉ-AURKA/N-Myc signaling to facilitate the neuroendocrine progression of prostate cancer.
Cell Death Dis
; 14(6): 384, 2023 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37385990
9.
Neurokinin-1 receptor promotes non-small cell lung cancer progression through transactivation of EGFR.
Cell Death Dis
; 13(1): 41, 2022 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35013118
10.
Inhibition of autophagy by YC-1 promotes gefitinib induced apoptosis by targeting FOXO1 in gefitinib-resistant NSCLC cells.
Eur J Pharmacol
; 908: 174346, 2021 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34270985
11.
YC-1 potentiates the antitumor activity of gefitinib by inhibiting HIF-1α and promoting the endocytic trafficking and degradation of EGFR in gefitinib-resistant non-small-cell lung cancer cells.
Eur J Pharmacol
; 874: 172961, 2020 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32044322
12.
Enhanced cell selectivity of hybrid peptides with potential antimicrobial activity and immunomodulatory effect.
Biochim Biophys Acta Gen Subj
; 1864(4): 129532, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31953126
13.
p53 as a double-edged sword in the progression of non-alcoholic fatty liver disease.
Life Sci
; 215: 64-72, 2018 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30473026
14.
Novel antimicrobial peptide CPF-C1 analogs with superior stabilities and activities against multidrug-resistant bacteria.
Chem Biol Drug Des
; 90(5): 690-702, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28371431
15.
Neurokinin-1 receptor mediated breast cancer cell migration by increased expression of MMP-2 and MMP-14.
Eur J Cell Biol
; 95(10): 368-377, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27498853
16.
Human hemokinin-1 promotes migration of melanoma cells and increases MMP-2 and MT1-MMP expression by activating tumor cell NK1 receptors.
Peptides
; 83: 8-15, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27458061